RET fusion-positive thyroid cancer

URI: https://gptkb.org/entity/RET_fusion-positive_thyroid_cancer
GPTKB entity
Statements (23)
Predicate Object
gptkbp:instanceOf gptkb:cancer
gptkbp:FDAApproved gptkb:pralsetinib
gptkb:selpercatinib
gptkbp:hasBiomarker gptkb:RET_fusion
gptkbp:hasCommonFusionPartner gptkb:CCDC6
gptkb:KIF5B
gptkb:NCOA4
gptkbp:hasDiagnosticMethod gptkb:FISH
gptkb:RT-PCR
next-generation sequencing
gptkbp:hasIncidenceInThyroidCancer 1-2%
gptkbp:hasMolecularAlteration gptkb:RET_gene_fusion
gptkbp:hasTargetedTherapy gptkb:pralsetinib
gptkb:selpercatinib
https://www.w3.org/2000/01/rdf-schema#label RET fusion-positive thyroid cancer
gptkbp:prevalence rare
gptkbp:prognosis variable
gptkbp:subspecies gptkb:papillary_thyroid_carcinoma
gptkb:anaplastic_thyroid_carcinoma
gptkb:poorly_differentiated_thyroid_carcinoma
gptkbp:bfsParent gptkb:pralsetinib
gptkb:selpercatinib
gptkbp:bfsLayer 6